A Vision of An Integrated Cancer Treatment Program
A Vision of An Integrated Cancer Treatment Program
Introduction
In our clinic , we strive to combine the best from both the traditional western medical approach with natural and holistic treatment perspectives. We are always updating our knowledge, and put all the new scientific discoveries we find on our scientific website www.medicdebate.org, where everyone is invited to help us keep track of all interesting new medical discoveries. Many of the most common cancers found in our society have been traditionally rare in other large populations in the world; studies of migrants exclude a simple genetic explanation for these wide geographical variations and imply that psychological and environmental exposures are key determinants of the development of these cancers. Our basic vision is that the most important issue for each patient is to learn how to connect to his her inner core, and learn how express that more and more, in order to create a life worth living, with lots of fun, love, creativity, healthy good food and meaningful interpersonal relationships. We have a team of professionals including holistically educated cancer doctors, oncologists, neurologists, immunologists, nutritionists, naturopaths, psychotherapists, fun lovers and biological dentists that can support you in your fight to become cancer free.
Creativity
We strongly recommend patients to engage in hobbies and creativity. It is never too late to start learning how to play that music instrument you were always dreaming to master, start painting, or writing the novel you always wanted to write. If you already are engaged in hobby activities, bring you music instrument, knitting set or painting gears with you. If not, we will do our best to provide you with whatever you need to enhance your creativity. It is much better to be engaged in positive and creative activities the being a conventional cancer patient, only waiting for next treatment, worrying and reading about cancer. We actually advice our clients to avoid all reading and other activities connected to cancer. It is our work to be updated and provide the best treatment available. We wish our clients to focus there entire attention on en!oying their lives and be as loving, loved and creative as possible.
Exercise
+here is overwhelming scientific evidence that exercise has a cancer preventive effect and also a positive effect on cancer survival. We encourage all our clients to have daily exercise. We have connections to a fully e,uipped gym, tennis courts and swimming)pool and have excellent walking possibilities in the surrounding forests and hills. We also provide yoga classes, physiotherapy and massage.
Diet
Many of today%s most challenging, costly and debilitating chronic disease conditions - including heart disease, +ype II diabetes, obesity, osteoporosis, digestive and autoimmune disorders as well as many types of cancers - have been demonstrably linked to suboptimal nutrition. Optimal nutrition creates a foundation all the way down at the cellular level for a strong and healthy body. +hrough understanding the relationship between our external environment .I.e. the food we ingest/ and our internal environment .cellular function fuelled by nutrient absorption/ we are able to achieve the complete, balanced nutrition essential to ensuring the harmonious system functioning that is at the core of what we think of as good health. Our program recogni0es that restoring nutritive balance is an essential part in order to promote healing in a body that is stressed by the burden of invasive chronic illness In most westernised societies, modern food production, processing and transport technologies as well as lifestyle have combined to create an environment in which convenience and preservation have largely replaced nutritional content as the dominant selection criteria driving food choices. +he unintended conse,uence has been a negatively charged version of 1We are what we eat2; without a doubt, this moderni0ation of our food supply chain has resulted in critical nutritional deficits that at minimum prevent optimum health, and may promote or even accelerate disease progress.
3our treatment program approaches nutrition from a healing perspective, approaching food as medicine. 4s a patient you will be 1prescribed2 with nutrition plan based on your uni,ue needs, with special special attention to identifying and addressing deficiencies, higher nutritional needs, and allergies - some you may not even be aware of having - as well as taste and appearance. We co)operate with some of the worlds most advanced food allergy and hormone laboratories in the 5# and also do determine correct assessments analysis with the help of dark field dark field microscopy and dried layers tests. 4nother dietary approach which we have found works very well is the 6udwig 7rotocol. 6asically this involves consuming as much flax seed oil blended with 0ero fat ,uark as you can. When you blend the two together with a hand blender the oil actually binds to the protein in the ,uark. +he oil then gradually replaces all the bad fats that may have got lodged in your cell walls, making them healthier and more alkaline. +here is also a very helpful free download book from the 6udwig $entre. 8ttp9 www.budwigcenter.com budwig)guide.php
Cancer psychotherapy
'r :rederick 6 ;evenson began his work with cancer patients in <=>?, when he started providing psychotherapy for a stage I( breast cancer patient, with the primary goal of aiding her capacity to regulate and discharge irritation. +o his astonishment, he discovered that the patient started to recover from her cancer, as she connected more and more to 'r. ;evenson in the psychotherapeutic process. In the end, she was totally free from cancer. 8e discovered that she was not the only one who could be healed from cancer by using this method, and over the years he refined his techni,ues, with even better results as a conse,uence. In @A<A a review was published of of 'r ;evenson%s records and the medical records of his patients during a BC year period. +his clearly demonstrated a positive effect on patient longevity and both observed and reported patient ,uality of life. In this paper >C cases treated during <=>? to @AAD were discussed. 4lmost all patients were diagnosed with 1incurable2 cancers treated by oncologists at esteemed medical centres. 4ll sub!ects within this sample, with the exception of two who died immediately after the initialisation of treatment experienced an improved ,uality of life according to case records and reviewed documentation; BB .??E/ are still alive, DAE survived for more than five years and ?CE survived for more than <A years. 4 noticeable trend of improved patient ,uality of life and longevity had occurred as ;evenson refined and improved his treatment methodology over the decades. +he patients often sought treatment after a terminal diagnosis, having been informed that allopathic biomedical interventions could not alter their prognosis. +here seemed to be an improvement in longevity and several spontaneous remissions were noted in the hospital documentation. +he basic principle of ;evenson +herapy is that cancer is not seen as a disease, but as a process, that can be reversed. Fveryone has cancer cells in his her body all the time, but
normally these cells are taken care of by the immune system, so that no serious problems will develop. $ancer cells are embryonic cells that do not complete their maturation process into fully differentiated, adult cells, and 'r ;evenson postulates that the reason for this lack of maturation of certain cells lies in early traumas, and lack of ade,uate emotional support in early childhood as well as later in life. In order to heal these often very early wounds and personality patterns, it is necessary to let the therapist become like a surrogate mother, who 1adopts2 the patient in order to give support through two ?C minute talks a week plus daily contact over the telephone for a couple of minutes. It is also always possible to call the therapist @? > in emergency situations. If you cannot come to the therapist physically, sessions can be performed over a land)line telephone or #kype.
Gc A!
+he first research was done in <==A by 'r 3amamoto in 7hiladelphia and since then over ?G research papers have been published by over <AA scientists indicating that HcM4: rebuilds the immune system, and the immune system then eradicates early stage cancer and other diseases. 8ow does HcM4: work" In a healthy person your HcM4: acts like the 1commanding officer2 of your immune system and also instructs macrophages in your bloodstream to scour our bodies and kill malignancies. 6ut malignant cells like cancer send out an en0yme called Iagalase that neutralises your HcM4:; so the macrophages never get the message to go into action - in this way disease suppresses the immune system, and cancer cells grow unchecked. In its role of immune system regulator, research shows HcM4: can reverse diseases that attack the immune system like chronic inflammation, bacterial and viral infections, 4utism, $hronic 8erpes, $hronic 4cne, $:#, JMK(, ;yme disease, 4I'#, 8I(, :ibromyalgia, osteoporosis, 8odgkin%s, ;upus, M#, 7arkinson%s, and various types of Immune dysfunction. 7rofessor Iobuto 3amamoto has published three scientific studies with excellent clinical results on breast, prostate and colorectal cancers. HcM4: is available both as in!ections you take intramuscularily or intravenously <)@ times week, and also as M4:B<? yoghurt. We recommend to combine both forms. +he youghurt have also proven to be extremely helpful to relieve gastrointestinal side effects from chemotherapy and to increase appetite, reduce weight loss and diminish nausea.
Psorinum
4t the 4#$O.4merican #ociety of $linical Oncology/ congress in $hicago from Lune ?th to Dth @A<A, the world%s most prestigious congress of clinical oncology with BA to BC,AAA participants, was published on the poster section a rather sensational result in the treatment of non)small cell lung cancer with an increase of five year survival from an expected M<E to ??E** +here are also extremely good results in the treatment of pancreatic cancer, liver cancer, gallbladder cancer, stomach cancer and oesophageal cancer.
7sorinum is an alcoholic extract of scabies, slough, and pus cells. 4ccording to the pre)clinical data, 17sorinum)Gx2 .1x2 stands for decimal potency of homoeopathy/ activates different immune effector cells .e.g., + cells, and accessory cells like, macrophages, dendritic cells, and natural killer cells/ which can trigger a complex antitumor immune response . I In an observational, open level and single arm study on<CD patients with histologically confirmed stomach, gall bladder, liver and pancreatic cancer, complete tumour response occurred in @D .<>.>@E/ cases and partial tumour response occurred in CG .BC.??E/ of cases +he participants% eligibility criteria included histopathology cytopathology confirmation of malignancy, inoperable tumour, and no prior chemotherapy or radiation therapy. +he primary outcome measures of the study were to assess the radiological tumor response to find out how many participants survived at least < year, @ years, B years, ? years and finally C years after the beginning of the study considering each type of cancer. 7sorinum)Gx was administered orally to all the participants up to A.A@ml Ng body weight as a single dose in empty stomach per day for @ years along with allopathic and homoeopathic supportive cares. +here were ?@ stomach cancers, ?A gall bladder cancers, ?? pancreatic cancers and B@ liver cancers included in the final analysis of the study. In this study, no adverse side effects were observed from the drug 7sorinum. 8owever, very few patients reported to have mild oral irritation and skin itching which were successfully controlled by the supportive cares. 7sorinum +herapy was also effective in improving the disease symptoms and the ,uality of life of the participants. 4t least GAE participants of stage)III and at least ?CE participants of stage)I( reported that the therapy was effective in reducing their cancer)related pain, cough, dyspnoea, nausea and vomiting, fatigue, constipation and improving appetite, and weakness. +hese were also confirmed after examining the participants clinically. Improvements were also observed in the lab investigations like $omplete 6lood $ount .$6$/, ;iver :unction +est .;:+/, Nidney function test, 4:7 level, and $4 <=.=. +hese lab investigations were done as a part of their routine clinical check ups. 4mong the <CD participants, =D [email protected]/ were aged GC years or more. 6etter outcomes were observed among the participants below GC years of age than the participants who were over the age of GC. +he outcomes did not vary significantly while considering gender. +he cumulative C)year survival was B=.@?E for patients who received 7sorinum treatment, compared with an estimated C)year survival of @BE for stomach cancer, <AE for liver cancer, M?E for pancreatic cancer and M<CE for gall bladder cancer for patients taking conventional therapies. @D patients .<>.>@E/ had a complete recovery from their cancer in this study. 7sorinum in the treatment of Ion #mall $ell ;ung $ancer.I#$;$/ In another phase II, open) level, single arm, and single stage study, also performed by 'r $hatter!e et al, =C participants were included with I#$;$. 4ccording to the 4L$$ +IM staging system, CD .G<.ACE/ of them diagnosed at stage I(. 4ccording to the KF$I#+ criteria, complete tumour response occurred in <= .@AE/ cases and partial tumour response occurred in @D .@=.?>E/ cases. D@ .DG.B@E/ of them survived at least < yr, >A .>B.GDE/ survived at least @ yrs, CD .G<.ACE/ survived at least B yrs, ?= .C<.CDE/ survived at least ? yrs, and ?@ .??.@<E/ of them survived at least C yrs. +hese participants did not receive chemotherapy, radiation therapy, or any other investigational cancer treatments. 7articipants reported no side effects from the drug 7sorinum.
Kegarding pancreatic cancer9 ?? patients participated in the study with 7sorinum 'G, A,A@ ml per kg body weight in the morning on empty stomach. #urvival after first year B?, after @ years @D, after B years @>, after ? years @<, and after C years <> of the patients were still alive, e,ual to a C)year survival of B=E ) 7robably the highest ever recorded C year survival on 7ancreatic $ancer published so far in medicine history** +hese results were examined by a very critical an independent expert commission at the Iational $ancer Institute in 6ethesda, near Washington '$, 5#4, who has accepted the results, so that 'r. $hatter!ee was able to present the results at the 4#$O conference. +here are plans to make more research on 7sorinum on the famous M' 4nderson $ancer Institute in 8ouston, +exas, 5#4 +he treatment is suitable for many more cancer types, but research has so far been focused on the more difficult cancers.
$urrently, these vaccines cannot be made anywhere on planet earth except in +allberg%s own laboratory, and as he is presently >> years old, he is trying to reduce his workload, and therefore does not accept new patients.
Targeted Therapies
+argeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and progression. 6ecause scientists often call these molecules 1molecular targets,2 targeted cancer therapies are sometimes called 1molecularly targeted drugs,2 1molecularly targeted therapies,2 or other similar names. 6y focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than other types of treatment, including chemotherapy and radiotherapy, and less harmful to normal cells. 6elow are some examples of targeted therapies9 Imatinib mesylate .HleevecO/ is approved to treat gastrointestinal stromal tumor .a rare cancer of the gastrointestinal tract/, certain kinds of
cancer as well as some types of gastric or gastroesophageal !unction adenocarcinoma. ;apatinib .+ykerbO/ is approved for the treatment of certain types of advanced or metastatic breast cancer. Hefitinib .IressaO/ is approved to treat patients with advanced non)small cell lung cancer. Frlotinib .+arcevaO/ is approved to treat metastatic non)small cell lung cancer and pancreatic cancer that cannot be removed by surgery or has metastasised. +his small) molecule drug inhibits the tyrosine kinase activity of FH:K. $etuximab .FrbituxO/ is a monoclonal antibody that is approved for treating some patients with s,uamous cell carcinoma of the head and neck or colorectal cancer. Fverolimus .4finitorO/ is approved to treat patients with advanced kidney cancer whose disease has progressed after treatment with other therapies, patients with subependymal giant cell astrocytoma who also have tuberous sclerosis and are unable to have surgery, or patients with pancreatic neuroendocrine tumors that cannot be removed by surgery, are locally advanced, or have metastasised. 6orte0omib .(elcadeO/ is approved to treat some patients with multiple myeloma. +he drug is also approved for the treatment of some patients with mantle cell lymphoma. 6evaci0umab .4vastinO/ is a monoclonal antibody that is approved for the treatment of glioblastoma. +he therapy is also approved for some patients with non)small cell lung cancer, metastatic colorectal cancer, and metastatic kidney cancer. #orafenib .IexavarO/ is a small)molecule inhibitor of tyrosine kinases that is approved for the treatment of advanced renal cell carcinoma and some cases of hepatocellular carcinoma. #unitinib .#utentO/ is another small)molecule tyrosine kinase inhibitor that is approved for the treatment of patients with metastatic renal cell carcinoma, gastrointestinal stromal tumour that is not responding to Imatinib, or pancreatic neuroendocrine tumours that cannot be removed by surgery, are locally advanced, or have metastasised. #unitinib blocks kinases involved in (FH: signalling, thereby inhibiting angiogenesis and cell proliferation. Kituximab .KituxanO/ is a monoclonal antibody that is approved to treat certain types of 6)cell non)8odgkin lymphoma and, when combined with other drugs, to treat chronic lymphocytic leukemia .$;;/. +he therapy recogni0es a molecule called $'@A that is found on 6 cells. When Kituximab binds to these cells, it triggers an immune response that results in their destruction. Kituximab may also induce apoptosis. Ipilimumab .3ervoyP/ is approved to treat patients with unresectable or metastatic melanoma. +his monoclonal antibody is directed against cytotoxic +)lymphocyte) associated antigen)? .$+;4)?/, which is expressed on the surface of activated + cells as part of a 1checkpoint2 to prevent a runaway immune response. 6y inhibiting $+;4)?, Ipilimumab stimulates the immune system to attack melanoma cells.
treat malignant ascites, a condition occurring in patients with metastasi0ing cancer. It binds to antigens $'B and Fp$4M.
"iphosphonates
:or patients with bone metastasis we use 6iphosphonates such as Qoledronic acid .Qometa/. +hese drugs stop the bones from being broken down by the cancer and also have some anti) cancer activity in their own right. We are mainly using a Rmetronomic% dosage of Qometa, with a S of the normal dose in!ected every week, instead of the full dose in!ected every month. In a clinical study from $hina, this dosage regimen has been proven to be better than the conventional schedule.
e$atonin
7rofessor ;issoni from Italy has performed many clinical studies on the positive effects of taking @A mg Melatonin at bedtime. It diminishes side )effects from chemotherapy, increases life ,uality and has also strong anti cancer effect son its own.
Itra*ona+o$e,-poranox.
In order to fight cancer, it is very important to kill all other bacteria%s and fungal infections, that takes away the attention of the immune system from killing the cancer. Itracona0ol is an anti) fungal medication, that besides killing fungi, also have a anti angiogenic effect, similar to metronomic chemotherapy, thereby cutting off the blood supply to cancer tumours.
etformin
Metformin is the drug of choice for the management of type @ diabetes mellitus. It improves insulin resistance and glycemic control and can safely be combined with other classes of anti) diabetic agents. Fxciting preclinical studies have shown that Metformin can inhibit the growth of cancer cells both cell culture tests and animal tests. +he recent evidence that Metformin results in .a/ initiation of an ;N6<)mediated 4M7N)dependent energy stress response that can adversely affect survival of cancer cell lines and .b/ inhibition of cancer related genes and proteins like phosphoinositide B)kinase 4kt m+OK has provided a molecular basis for a direct, insulin) independent antitumor effect and strengthened the rationale to evaluate Metformin in cancer clinical trials +he association of Metformin with reduced cancer mortality provides the rationale for the study of Metformin in the cancer treatment setting. 4 recent retrospective study in breast cancer patients showed that diabetic cancer patients treated with Metformin and neoad!uvant chemotherapy had a higher pathological complete response rate than the control groups. 4 phase III ad!uvant trial of metformin is currently being launched by Iational $ancer Institute $anada and Iational $ancer Institute 5nited #tates to assess the efficacy of Metformin in reducing breast cancer recurrence in B,CD@ women with stage I and II breast cancer .@/. 4t the Furopean Institute of Oncology, the 'ivision of $ancer 7revention and Henetics is planning to conduct a clinical trial to evaluate the activity of Metformin on tumour cell proliferation in breast cancer patients undergoing surgery.
Disu$firam ,Anta%us.
Kecent studies have disclosed a surprising, but mechanistically consistent, anticancer activity of 'isulfiram .4ntabus/, a drug used for about CA years in the treatment of alcoholism. 'isulfiram has been successfully used to suppress hepatic metastases originating from ocular melanoma. +he pharmacokinetics of 'isulfiram and its pharmacological profile in cancer cell lines and in cancer cells obtained from patients is well known. 'isulfiram is a readily available and inexpensive substance whose adverse effects are negligible, compared to classical cancerostatics.
Anti#inf$ammatory medication
$ancer creates a wound inside,. and sometimes also outside/ the body. It then uses the bodies wound healing mechanism, which is inflammation, in order to increase the blood supply to the cancer itself. +here are numerous studies showing positive effect of anti)inflammatory medicines on cancer survival. +he most common anti)inflammatory medicines the so called I#4I' medications like 4spirin, (oltaire, Ibuprofen etc., the newer $ox @ inhibitors like $elebra.$elecoxib/ and $orticosteroids .7rednisone, 6etapred etc./
We also use natural anti)inflammatory medicines like 6oswellia #errata.:rankincense/, +urmeric, and Hinger.
+he technology was developed in Iovosibirsk, Kussia, and has successfully treated thousands of cancer patients without any serious side effects.
E$ectrotherapy
WM$# .Wireless Micro $urrent #timulation/ is a new method for electrical stimulation of wounds. F# is recogni0ed in more than CAA published articles as the most efficient method in wound care. +he WM$# method transfers the electrical charges wirelessly to the wound, which makes the method significantly more useful than the previously known transferring methods. +he WM$# method uses oxygen to transport electrons to a 2plate out2 effect on the wound, which means that the molecules deposits the electron, when they touch the wound or skin surface , while the oxygen molecule carries on as air gas. +he basis for a current is the movement of electrons and with this simple method the WM$# technology transfers the current to the wound, where the so)called 2current of in!ury2 is established and supports the natural bio) electrical process of the wound healing. WM$# has been proven to help the healing of cancer in many case reports.
Papimi Therapy
7apimi device is a pulsed electromagnetic field generator. It is also related with bioresonance and fre,uency therapy. +he produced nanopulses are characteri0ed by high intensity and very short duration. +he high power of the device and the uni,ue way of function are the reasons of the wide range of applications and the remarkable results it shows. It is applied externally over the skin, by induction, .even over the clothes/, painless, without any significant restrictions and without increasing tissues% temperature. In addition no considerable adverse effects have been reported over the twenty)year application of the device. It has been used to treat sport in!uries, cancer and many other diseases.
0er%a$ treatments
We use a wide variety of herbal treatments with scientifically proven anti)cancer properties. We can here mention 6lood root, #anguinaria $andensis, a plant use both internally and as the main ingredient in so called cancer salves, that has been used for treatment of cancer since many hundred of years with successful results. 6loodroot is often used for treatment of veterinary cancers. +here are hundreds of scientific papers on the many strong and powerful anti)cancer effects of blood root. 4nother anti cancer herb is milk thistle, #ilybum marianum. It has been utili0ed for thousands of years to remedy a variety of ailments, particularly liver and gall bladder problems. #cientific studies suggest that substances in milk thistle .especially a flavonoid called silymarin/ act to protect the liver from toxins, including certain drugs such as acetaminophen .+ylenol/, which in high doses .or in combination with alcohol/ can cause liver damage. #ilymarin has antioxidant and anti) inflammatory properties, and is thought to help the liver repair itself by growing new cells.
ist$etoe
7reparations from the Furopean mistletoe .(iscum album ;./ are among the most prescribed drugs in cancer patients in several Furopean countries. +he most common brand names are Iscador, 8elixor and (iscum 4lbum. $ontrolled $linical +rials In a randomi0ed controlled study from @AAD on altogether CAD patients Iscador was shown to prolong overall survival of corpus uteri cancer patients. 7sychosomatic self)regulation as a measure of autonomous coping with the disease, rised significantly more under Iscador therapy than under conventional therapy alone at a follow up of <@ months. +reatment with 8F;IJOK proved to be beneficial for breast cancer patients since it significantly improved ,uality of life and significantly reduced persistent signs symptoms of the disease treatment during the validated after)care period of approximately five years in <G> patients treated with 8elixor. In an open study from @AAD BB patients with primary breast cancer receiving ad!uvant chemotherapy and simultaneous treatment with Iscador was compared with BB controls without mistletoe therapy. Keductions in ,uality of life seemed to be smaller during add)on)therapy with mistletoe. ;aboratory parameters showed no difference compared to the control group. Mistletoe patients showed better ,uality of life and a reduction of in the need of symptom relieving glucocorticoid.cortisone/ co)treatment. 4 study on altogether <A patients with early stage cervix cancer and healthy volunteers showed that dose)escalation of Iscador reduces the monocyte)related clinical side effects, like temperature increase and skin reactions. +he most interesting clinical long)term effect is the bystander stimulation of various memory + cells that might mediate in vivo antitumor and antiinfectious +)cell response under mistletoe)extract immuni0ation. In three controlled cohort studies with altogether B>? patients, Iscador may have the effect of prolonging overall survival of cervical cancer patients. In the short term, psychosomatic self)
regulation increases more markedly under complementary Iscador therapy than under conventional therapy alone. Hrossarth et al found in @AAG that Iscador showed a clinically relevant effect on breast tumour progression as measured by overall survival as well as by the time to recurrences, lymphatic or distant metastases on @?? patients with breast cancer. In the short term, psychosomatic self) regulation increased more markedly under complementary Iscador therapy than under conventional therapy alone.
1*rain
5krain, also called I#$ GB<C>A is an experimental anticancer drug invented by the 5krainian researcher Wassil Iowicky and tested clinically for the first time in <=>D. It is a product that results from a reaction of alkaloids from greater celandine with the classic cancer medicine +hio)+F74 in the presence of hydrochloric acid. $ontent 5krain contents mixture of alkaloids. $helidonine is generally considered the most important one. $helidonine, like some other celandine alkaloids, is hardly soluble in water. +his makes intravenous in!ections impossible. +he preparation of 5krain together with +hio)+F74 and hydrochloric acid makes the alkaloids water soluble and in!ectable. addition. It is probable the anti)cancer effect of 5krain is a result of a combined action of all its constituents. 7reviously it has been postulated that the active component of 5krain was a trimeric structure containing three chelidonine molecules connected by a +hiro)thepa skeleton. +his has not been confirmed in later investigations. $linical Investigations 5krain has been investigated in multiple phase I and phase II clinical trials on a large variety of cancer types with very promising results. 5krain can also have a possible future role in the treatment of 8epatitis $ and other viral infections. $lick on this link to go to a summary of all the clinical investigations and case reports on 5krain
Anti#Cancer
ushrooms
+here is an estimated BD,AAA species of mushroom, only about B,AAA are edible, about >AA have known medicinal properties, and less than one percent are recogni0ed as poisonous. 6ut even these poisonous mushrooms when properly elaborated in a laboratory are proving to have some outstanding health benefits. Mushrooms have been used in +raditional $hinese Medicine for thousands of years. Fach time we get sick, our immune system weakens and may become more inade,uate or sub!ect to malfunction. #elected mushrooms have been effectively used to boost the immune
system to fight a host of diseases, including even deadly cancer. #ome of the names of these mushrooms are ;ions mane, #hiitake, Maitake, $oryolis (ersicolor etc.
Amanita Pha$$oides
#everal doctors working in cancer clinics for the past C years are reporting very positive results in treating every type of cancer with the diluted poison from 'eath $ap.4manita 7halloides/. Often in a matter of days tumours start to dissolve and patients feel their condition changing. +he Furopean laboratory have made it to safe specification without losing its potency and the doctors using the formula have reported no serious side effects, except from some increased bowel activity date +his therapy does not affect the activity of somatic cells and works by greatly enhancing the immune system